Copanlisib
Back to search| Scientific Name: | Copanlisib |
| Brand Name: | Aliqopa |
| Company Owner: | Not Available |
| Mechanism Of Action | Follicular lymphoma is a B-cell lymphoma that is one of the most common type of non-Hodgkin lymphoma (NHL) . It involves unregulated growth and proliferation of lymphocytes that eventually may travel to other organs including the lymph nodes, spleen, and the bone marrow, to form tumors. The phosphatidylinositol 3-kinase (PI3K) -mediated pathway is involved in promoting cell survival proliferation and differentiation however abberant activation of this pathway may lead to tumorigenesis |
| Description of the Drug: | Copanlisib is a medication used to treat relapsed follicular lymphoma who have attempted at least two other treatments. |
| Protein Data Bank: |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB12483
